ZC3H15

ZC3H15 (DFRP1/LEREPO4) is a conserved, predominantly cytoplasmic eukaryotic protein that functions both in translation and in the post-translational control of protein stability (PMID:19819225, PMID:23624947). Through its DFRP domain it forms a stable complex with the potassium-dependent GTPase DRG1, stimulating DRG1 GTPase activity approximately four-fold and increasing its thermal stability without altering nucleotide affinity, with the TGS domain of DRG1 mediating this action (PMID:23711155); the resulting complex co-sediments with polysomes, placing ZC3H15 at translating ribosomes (PMID:19819225). Consistent with a translation-associated role, deletion of the yeast ortholog TMA46 perturbs elongation processivity and resolution of ribosome stalling/collisions and interacts genetically with the RQT helicase component SLH1/ASCC3 (PMID:34900236). Independently, ZC3H15 governs the stability of multiple cancer-relevant proteins by tuning their ubiquitination: it suppresses transcription of the E3 ligases CBL and FBXW7 to stabilize EGFR and c-Myc respectively (PMID:35027542, PMID:35064102), directly binds PTEN via its DFRP domain and recruits the E3 ligase TRIM56 to drive PTEN degradation and AKT-mTOR activation (PMID:41513632), and maintains KEAP1 stability to promote NRF2 ubiquitination and degradation under oxidative stress (PMID:39908779). ZC3H15 also binds TERT in an RNA-dependent manner and associates with GEM nuclear bodies, where it anchors telomerase away from Cajal bodies to enable telomere elongation, such that its loss sequesters telomerase in Cajal bodies and causes telomere shortening and senescence (PMID:40696438).

1. 2009 Medium

   Established that ZC3H15 is not a free-standing factor but a stable partner of the GTPase DRG1 acting at the translation machinery, framing its core biochemical role.

   Evidence Polysome co-sedimentation and complex-disruption stability analysis in mammalian cells

   PMID:19819225

   Open questions at the time

   • Does not define which subunit is stabilized or the molecular basis of complex assembly
   • No direct readout of an effect on translation output
2. 2013 High

   Defined the precise biochemical function of ZC3H15 as a DFRP-domain-dependent activator of DRG1 GTPase activity and stabilizer, resolving how it acts on its partner.

   Evidence Purified-protein reconstitution, in vitro GTPase and thermal stability assays, domain-deletion and phosphomimicking mutagenesis

   PMID:23711155

   Open questions at the time

   • The downstream consequence of GTPase stimulation for ribosome function not directly measured
   • Physiological regulation of the interaction (e.g. phosphorylation) not established in cells
3. 2013 Low

   Placed ZC3H15 in the cytoplasm and linked it to TRAF-2/NF-κB signaling, raising a non-translational signaling role.

   Evidence Immunofluorescence, subcellular fractionation, and Co-IP in HeLa cells

   PMID:23624947

   Open questions at the time

   • TRAF-2 interaction rests on a single Co-IP without reciprocal validation or functional epistasis
   • Localization not tied to a functional consequence
4. 2021 Medium

   Connected the DRG1-partner function to a concrete translational phenotype, implicating ZC3H15/TMA46 in ribosome-associated quality control rather than bulk translation alone.

   Evidence Ribo-Seq and RNA-Seq of TMA46 knockout S. cerevisiae

   PMID:34900236

   Open questions at the time

   • Mechanistic link to the RQT complex is genetic, not biochemical
   • Conservation of this RQC role to the human protein not demonstrated
5. 2022 Medium

   Revealed a second, transcription-linked mode of action whereby ZC3H15 stabilizes oncoproteins (EGFR, c-Myc) by repressing transcription of their cognate E3 ligases (CBL, FBXW7).

   Evidence siRNA knockdown, ubiquitination/stability assays, E3-ligase transcription analysis, and epistasis rescue in GBM and gastric cancer cells

   PMID:35027542 PMID:35064102

   Open questions at the time

   • Mechanism by which ZC3H15 represses CBL/FBXW7 transcription is unknown
   • Whether ZC3H15 acts directly on chromatin or transcription factors not addressed
6. 2025 Medium

   Showed ZC3H15 directly modulates the ubiquitination of stress and tumor-suppressor proteins, stabilizing KEAP1 to promote NRF2 degradation under oxidative stress.

   Evidence Co-IP, in vivo/in vitro ubiquitination assays, AAV-shRNA knockdown in a mouse BCP model with NRF2-deletion rescue

   PMID:39908779

   Open questions at the time

   • Whether ZC3H15 binds KEAP1 directly or via an intermediary not resolved
   • Relationship between this KEAP1/NRF2 role and the DRG1-translation function unclear
7. 2025 Medium

   Identified a nuclear, RNA-dependent role for ZC3H15 in telomere maintenance through spatial control of telomerase between GEM and Cajal bodies.

   Evidence Genome-wide TriFC screen, PhastID proximity labeling, Co-IP, live-cell imaging, and telomerase activity assays in HTC75 cells

   PMID:40696438

   Open questions at the time

   • How a largely cytoplasmic protein partitions to nuclear bodies is unexplained
   • The RNA mediating the TERT interaction is not identified
8. 2026 Medium

   Demonstrated that ZC3H15 can directly recruit an E3 ligase rather than only repress one, binding PTEN via its DFRP domain and recruiting TRIM56 to activate AKT-mTOR.

   Evidence Co-IP, DFRP domain-binding assays, ubiquitination assays, and knockdown/overexpression in NSCLC cells

   PMID:41513632

   Open questions at the time

   • Whether DFRP domain binding to PTEN competes with its DRG1 binding is untested
   • Generality of the TRIM56-recruitment mechanism to other substrates unknown

• It remains unknown how ZC3H15's conserved DRG1/translation function mechanistically connects to its diverse roles in oncoprotein ubiquitination and telomerase spatial control, and whether these represent one integrated mechanism or independent activities.
• No unifying biochemical model links the DFRP-DRG1 axis to E3-ligase modulation
• Whether the ubiquitination phenotypes are downstream of altered translation has not been tested